Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain)

被引:20
作者
Gibb, TR [1 ]
Norwood, DA [1 ]
Woollen, N [1 ]
Henchal, EA [1 ]
机构
[1] USA, DSD, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA
关键词
D O I
10.1128/CDLI.9.1.19-27.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to characterize the cellular response to and identify potential diagnostic markers for the early detection of Ebola virus, an in vitro culture system involving nonhuman primate alveolar macrophages was developed. Ebola virus replication in the alveolar macrophages was characterized by plaque assay, immunohistochemical analysis, and in situ hybridization. Fluorogenic 5'-nuclease assays specific for nonhuman primate proinflammatory cytokines and chemokines were designed and used to evaluate mRNA transcription in macrophages infected with Ebola virus. Transient increases in cytokine and chemokine mRNA levels were observed immediately following exposure to Ebola virus. At 2 h postexposure, levels of cytokine and chemokine mRNAs were markedly reduced. Although Ebola virus infection of alveolar macrophages failed to induce a sustained increase in proinflammatory cytokine and chemokine mRNA transcription (potentially reducing the use of these markers as diagnostic tools), the fluorogenic 5'-nuclease assays developed may have prognostic value for individuals infected with Ebola virus. Recently published data have indicated that persons who remain asymptomatic after exposure to Ebola virus are capable of mounting an early proinflammatory cytokine response and that those who become clinically ill are not. If implemented immediately after exposure, these assays could be used to predict which individuals will be more likely to remain asymptomatic as opposed to those who will be more likely to develop clinical signs and eventually succumb to the virus.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 34 条
[1]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[2]  
BAZHUTIN NB, 1992, VOP VIRUSOL+, V37, P153
[3]  
BIRON CA, 2001, FIELDS VIROLOGY, P321
[4]  
Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
[5]  
*CDCP, 1995, MMWR-MORBID MORTAL W, V44, P468
[6]  
Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P475
[7]  
Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P266
[8]   Pathogenesis of experimental Ebola virus infection in guinea pigs [J].
Connolly, BM ;
Steele, KE ;
Davis, KJ ;
Geisbert, TW ;
Kell, WM ;
Jaax, NK ;
Jahrling, PB .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S203-S217
[9]  
DALGARD DW, 1992, LAB ANIM SCI, V42, P152
[10]  
Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805